These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 990989)

  • 1. Structure and function of insulin: preparation and biological activity of guinea pig des B-Asp30,des-A-Asn21-insulin.
    Yip CC; Moule ML
    Can J Biochem; 1976 Oct; 54(10):866-71. PubMed ID: 990989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoaffinity labeling of insulin receptor with an insulin analogue selectively modified at the amino terminal of the B chain.
    Yeung CW; Moule ML; Yip CC
    Biochemistry; 1980 May; 19(10):2196-203. PubMed ID: 6990974
    [No Abstract]   [Full Text] [Related]  

  • 3. Structure and function relationships of insulin. Preparation, characterization, and biological activity of three bovine insulin derivatives selectively modified at the NH2-terminal of the B chain.
    Yeung CW; Moule ML; Yip CC
    J Biol Chem; 1979 Oct; 254(19):9453-7. PubMed ID: 489544
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of des(tetrapeptide B(1-4)) and des(pentapeptide B(1-5)) human insulins. Two biologically active analogues.
    Schwartz G; Katsoyannis PG
    Biochemistry; 1978 Oct; 17(21):4550-6. PubMed ID: 718857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NA1, NA1, NA1-trimethylinsulin--an insulin analogue with a quaternary amino group at the A1 terminus.
    Drewes SE; Magojo HE; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):745-53. PubMed ID: 7024089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and biological properties of [LeuB24, LeuB25]human insulin.
    Jonczyk A; Keefer LM; Naithani VK; Gattner HG; De Meyts P; Zahn H
    Hoppe Seylers Z Physiol Chem; 1981 May; 362(5):557-61. PubMed ID: 7019034
    [No Abstract]   [Full Text] [Related]  

  • 7. A highly potent insulin: des-(B26-B30)-[AspB10,TyrB25-NH2]insulin(human).
    Schwartz GP; Burke GT; Katsoyannis PG
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):458-61. PubMed ID: 2643113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor binding and biological activity of [SerB24]-insulin, an abnormal mutant insulin.
    Kobayashi M; Haneda M; Maegawa H; Watanabe N; Takada Y; Shigeta Y; Inouye K
    Biochem Biophys Res Commun; 1984 Feb; 119(1):49-57. PubMed ID: 6367745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin. Studies in cultured IM-9 lymphocytes and in vivo and in vitro in rats.
    Peavy DE; Brunner MR; Duckworth WC; Hooker CS; Frank BH
    J Biol Chem; 1985 Nov; 260(26):13989-94. PubMed ID: 4055768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological activity in vitro and in vivo of different insulin derivatives (author's transl)].
    Rager K; Buss U
    Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):847-51. PubMed ID: 1181277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 1. [21-Desasparagine,20-cysteinamide-A]insulin and [21-desasparagine,20-cysteine isopropylamide-A]insulin.
    Chu YC; Wang RY; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1987 Nov; 26(22):6966-71. PubMed ID: 3322393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nature of the B10 amino acid residue. Requirements for high biological activity of insulin.
    Burke GT; Schwartz G; Katsoyannis PG
    Int J Pept Protein Res; 1984 Apr; 23(4):394-401. PubMed ID: 6373642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A shortened insulin with full in vitro potency.
    Fischer WH; Saunders D; Brandenburg D; Wollmer A; Zahn H
    Biol Chem Hoppe Seyler; 1985 May; 366(5):521-5. PubMed ID: 3890892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulin.
    Schwartz GP; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1983 Sep; 22(19):4561-7. PubMed ID: 6354263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin receptors on pancreatic acinar cells in guinea pigs.
    Sjödin L; Holmberg K; Lyden A
    Endocrinology; 1984 Sep; 115(3):1102-9. PubMed ID: 6086285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoaffinity labeling of insulin receptor proteins of liver plasma membrane preparations.
    Yip CC; Yeung CW; Moule ML
    Biochemistry; 1980 Jan; 19(1):70-6. PubMed ID: 6986166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of isolated bovine adipocytes: validation of use for studies characterizing insulin sensitivity and binding.
    Vasilatos R; Etherton TD; Wangsness PJ
    Endocrinology; 1983 May; 112(5):1667-73. PubMed ID: 6299704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of insulin-induced receptor loss and evidence for internalization of the insulin receptor.
    Marshall S; Olefsky JM
    Diabetes; 1981 Sep; 30(9):746-53. PubMed ID: 7021273
    [No Abstract]   [Full Text] [Related]  

  • 19. Receptor binding studies on A1-(2-nitro-4-trimethylammoniophenyl)insulin.
    Lesniak M; Gliemann J; Roth J; Easter BR; Sutton DA; Drewes SE
    Hoppe Seylers Z Physiol Chem; 1979 Mar; 360(3):467-71. PubMed ID: 437696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid down regulation of insulin receptors in adipocytes artifact of the incubation buffer.
    Rennie P; Gliemann J
    Biochem Biophys Res Commun; 1981 Oct; 102(3):824-31. PubMed ID: 7030346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.